Hyaluronan microspheres for sustained gene delivery and site-specific targeting.
暂无分享,去创建一个
Weiliam Chen | Y. Yun | Paige Yellen | D. J. Goetz | Weiliam Chen | Yang H Yun | Douglas J Goetz | Paige Yellen
[1] M. Cybulsky,et al. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.
[2] D. Messadi,et al. Binding and internalization of hyaluronate by human cutaneous fibroblasts. , 1992, Matrix.
[3] G. Molema,et al. Selective Intracellular Delivery of Dexamethasone into Activated Endothelial Cells Using an E-Selectin-Directed Immunoconjugate , 2002, The Journal of Immunology.
[4] K. Goa,et al. Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. , 1994, Drugs.
[5] G. Prestwich,et al. Novel Hydrogels of Hyaluronic Acid: Synthesis, Surface Morphology, and Solid-State NMR , 1994 .
[6] G S Kansas,et al. Selectins and their ligands: current concepts and controversies. , 1996, Blood.
[7] Robert Langer,et al. Biodegradable Polymer Scaffolds for Tissue Engineering , 1994, Bio/Technology.
[8] S. Badylak. Modification of Natural Polymers , 2002 .
[9] E. Turley,et al. Rapid hyaluronan uptake is associated with enhanced motility: implications for an intracellular mode of action , 1998, FEBS letters.
[10] G. Prestwich,et al. Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials. , 1994, Bioconjugate chemistry.
[11] L. Juhlin. Hyaluronan in skin , 1997, Journal of internal medicine.
[12] W. Godwin. Article in Press , 2000 .
[13] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[14] B. Toole,et al. Hyaluronan in morphogenesis , 1997, Seminars in cell & developmental biology.
[15] R. Cotran,et al. Identification of an inducible endothelial-leukocyte adhesion molecule. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Allport,et al. CD11b/CD18‐coated microspheres attach to E‐selectin under flow , 2000, Journal of leukocyte biology.
[17] D. Nance,et al. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility [published erratum appears in J Cell Biol 1992 Aug;118(3):753] , 1992, The Journal of cell biology.
[18] J. Scott,et al. Extracellular matrix, supramolecular organisation and shape. , 1995, Journal of anatomy.
[19] Peter Carmeliet,et al. Growing better blood vessels , 2001, Nature Biotechnology.
[20] B. Furie,et al. Expression cloning of a functional glycoprotein ligand for P-selectin , 1993, Cell.
[21] N A Peppas,et al. New challenges in biomaterials. , 1994, Science.
[22] L. Cipelletti,et al. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. , 2002, Blood.
[23] E. Balazs,et al. The chemistry, biology and medical applications of hyaluronan and its derivatives , 1998 .
[24] U. Rothe,et al. Selectins as new targets for immunoliposome-mediated drug delivery. A potential way of anti-inflammatory therapy. , 1998, Pharmaceutica acta Helvetiae.
[25] E. Topp,et al. Microspheres of hyaluronic acid esters—Fabrication methods and in vitro hydrocortisone release , 1990 .
[26] G. Farrar,et al. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[27] G. Prestwich,et al. Chemical Modification of Hyaluronic Acid for Drug Delivery, Biomaterials and Biochemical Probes , 1998 .
[28] P. B. Deasy,et al. Microencapsulation and related drug processes , 1984 .
[29] J. Clegg,et al. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. , 1997, Vaccine.
[30] E. Balazs,et al. Clinical uses of hyaluronan. , 2007, Ciba Foundation symposium.
[31] Douglas J. Goetz,et al. Ligand Coated Nanosphere Adhesion to E- and P-Selectin under Static and Flow Conditions , 2001, Annals of Biomedical Engineering.
[32] David D Spragg,et al. Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[33] L. McIntire,et al. Cell Adhesion Under Hydrodynamic Flow Conditions , 1995, Current protocols in immunology.
[34] K. Paigen,et al. A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.
[35] D J Berry,et al. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[36] E. Coligan. Current protocols in immunology , 1991 .
[37] B. Ponder,et al. Organ-related differences in binding of Dolichos biflorus agglutinin to vascular endothelium. , 1983, Developmental biology.
[38] D. Jones,et al. Antigenic heterogeneity of renal endothelium , 1989, The Journal of pathology.
[39] D. Crommelin,et al. Adhesion molecules: a new target for immunoliposome‐mediated drug delivery , 1995, FEBS letters.
[40] J M Davidson,et al. Hyaluronate derivatives and their application to wound healing: preliminary observations. , 1991, Clinical materials.
[41] K. Comess,et al. Isolated P-selectin Glycoprotein Ligand-1 Dynamic Adhesion to P- and E-selectin , 1997, The Journal of cell biology.
[42] G. Kwon,et al. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[43] A. Harris,et al. The increased expression of adhesion molecules ICAM‐3, E‐ and P‐selectins on breast cancer endothelium , 1995, The Journal of pathology.
[44] B. Gerdin,et al. Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation , 1997, Journal of internal medicine.
[45] Anthony Atala,et al. Methods Of Tissue Engineering , 2006 .
[46] J. Dickerson,et al. Limited adhesion of biodegradable microspheres to E- and P-selectin under flow. , 2001, Biotechnology and bioengineering.
[47] Y. Hsu,et al. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres. , 1999, Journal of drug targeting.
[48] E. Berg,et al. Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectin. , 1998, Journal of immunology.
[49] F. Luscinskas,et al. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. , 1996, Annual review of medicine.
[50] R. Langer,et al. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. , 2000, Accounts of chemical research.
[51] B. Toole. Hyaluronan and its binding proteins, the hyaladherins. , 1990, Current opinion in cell biology.
[52] Weiliam Chen,et al. Characterization of DNA-hyaluronan matrix for sustained gene transfer. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[53] S. Slack,et al. Particle diameter influences adhesion under flow. , 2001, Biophysical journal.
[54] T. Laurent,et al. Catabolism of hyaluronan , 1998 .
[55] K. March,et al. Gene therapy for restenosis: getting nearer the heart of the matter. , 1998, Circulation research.